» Articles » PMID: 17121838

Food Intake Regulates Oleoylethanolamide Formation and Degradation in the Proximal Small Intestine

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2006 Nov 24
PMID 17121838
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Oleoylethanolamide (OEA) is a lipid mediator that inhibits food intake by activating the nuclear receptor peroxisome proliferator-activated receptor-alpha. In the rodent small intestine OEA levels decrease during food deprivation and increase upon refeeding, suggesting that endogenous OEA may participate in the regulation of satiety. Here we show that feeding stimulates OEA mobilization in the mucosal layer of rat duodenum and jejunum but not in the serosal layer from the same intestinal segments in other sections of the gastrointestinal tract (stomach, ileum, colon) or in a broad series of internal organs and tissues (e.g. liver, brain, heart, plasma). Feeding also increases the levels of other unsaturated fatty acid ethanolamides (FAEs) (e.g. linoleoylethanolamide) without affecting those of saturated FAEs (e.g. palmitoylethanolamide). Feeding-induced OEA mobilization is accompanied by enhanced accumulation of OEA-generating N-acylphosphatidylethanolamines (NAPEs) increased activity and expression of the OEA-synthesizing enzyme NAPE-phospholipase D, and decreased activity and expression of the OEAdegrading enzyme fatty acid amide hydrolase. Immunostaining studies revealed that NAPE-phospholipase D and fatty acid amide hydrolase are expressed in intestinal enterocytes and lamina propria cells. Collectively, these results indicate that nutrient availability controls OEA mobilization in the mucosa of the proximal intestine through a concerted regulation of OEA biosynthesis and degradation.

Citing Articles

Engineered probiotics introduced to improve intestinal microecology for the treatment of chronic diseases: present state and perspectives.

Guo J, Zhou B, Niu Y, Liu L, Yang L J Diabetes Metab Disord. 2023; 22(2):1029-1038.

PMID: 37975092 PMC: 10638336. DOI: 10.1007/s40200-023-01279-1.


Olive oil-derived endocannabinoid-like mediators inhibit palatable food-induced reward and obesity.

Forte N, Roussel C, Marfella B, Lauritano A, Villano R, De Leonibus E Commun Biol. 2023; 6(1):959.

PMID: 37735539 PMC: 10514336. DOI: 10.1038/s42003-023-05295-y.


Small Molecule Activation of NAPE-PLD Enhances Efferocytosis by Macrophages.

Zarrow J, Alli-Oluwafuyi A, Youwakim C, Kim K, Jenkins A, Suero I ACS Chem Biol. 2023; 18(8):1891-1904.

PMID: 37531659 PMC: 10443532. DOI: 10.1021/acschembio.3c00401.


The 16α-hydroxylated Bile Acid, Pythocholic Acid Decreases Food Intake and Increases Oleoylethanolamide in Male Mice.

Higuchi S, Wood C, Nasiri R, Giddla L, Molina V, Diarra R Endocrinology. 2023; 164(9).

PMID: 37490843 PMC: 10407715. DOI: 10.1210/endocr/bqad116.


"To brain or not to brain": evaluating the possible direct effects of the satiety factor oleoylethanolamide in the central nervous system.

Romano A, Friuli M, Eramo B, Gallelli C, Koczwara J, Karimian Azari E Front Endocrinol (Lausanne). 2023; 14:1158287.

PMID: 37234803 PMC: 10206109. DOI: 10.3389/fendo.2023.1158287.


References
1.
Tsuboi K, Hilligsmann C, Vandevoorde S, Lambert D, Ueda N . N-cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase. Biochem J. 2003; 379(Pt 1):99-106. PMC: 1224050. DOI: 10.1042/BJ20031695. View

2.
Broberger C . Brain regulation of food intake and appetite: molecules and networks. J Intern Med. 2005; 258(4):301-27. DOI: 10.1111/j.1365-2796.2005.01553.x. View

3.
Overton H, Babbs A, Doel S, Fyfe M, Gardner L, Griffin G . Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab. 2006; 3(3):167-75. DOI: 10.1016/j.cmet.2006.02.004. View

4.
Gomez R, Navarro M, Ferrer B, Trigo J, Bilbao A, Del Arco I . A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci. 2002; 22(21):9612-7. PMC: 6758016. View

5.
Shi Y, Burn P . Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Nat Rev Drug Discov. 2004; 3(8):695-710. DOI: 10.1038/nrd1469. View